Life Science Advisor, Exalen Consulting
Sterling is a seasoned business executive who started with a 20-year career with Elanco, the agriculture division of Eli Lilly & Co. After leaving Lilly he spent the next 20 years with public and private medical device and pharma companies as CEO or head of business development. Since 2010 Sterling has focused on business development for early-stage biotech and medtech businesses. He has lived and worked in Europe, Australia, Japan, and several USA locations. Sterling has negotiated numerous successful partnering, license, and JV agreements in the USA, Europe and Asia.